EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microbiota-centered interventions to boost immune checkpoint blockade therapies

Andrew A Almonte iD, Simon Thomas iD, Laurence Zitvogel iD

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20250378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Andrew A Almonte und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gustave Roussy Cancer Campus, Clinicobiome , Villejuif, France. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Gastrointestinal Microbiome, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade therapies have markedly advanced cancer treatment by invigorating antitumor immunity and extending patient survival. However, therapeutic resistance and immune-related toxicities remain major concerns. Emerging evidence indicates that microbial dysbiosis diminishes therapeutic response rates, while a diverse gut ecology and key beneficial taxa correlate with improved treatment outcomes. Therefore, there is a growing understanding that manipulating the gut microbiota could boost therapy efficacy. This review examines burgeoning methods that target the gut microbiome to optimize therapy and innovative diagnostic tools to detect dysbiosis, and highlights challenges that remain to be addressed in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsGastrointestinal MicrobiomeNeoplasmsImmunotherapyHumansDysbiosisAnimals

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Gustave Roussy Cancer Campus, Clinicobiome , Villejuif, France.
  • Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale Contre le Cancer , Villejuif, France.
  • Université Paris-Saclay , Kremlin-Bicêtre, France.
  • Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS) 1428 , Villejuif, France.

ORCID-Profile: Andrew A Almonte, Simon Thomas, Laurence Zitvogel

Zitieren

APA

Almonte, A. A., Thomas, S., & Zitvogel, L. (2025). Microbiota-centered interventions to boost immune checkpoint blockade therapies. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250378

Vancouver

Almonte AA, Thomas S, Zitvogel L. Microbiota-centered interventions to boost immune checkpoint blockade therapies. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250378

BibTeX
@article{Almonte2025,
  author = {Almonte, Andrew A and Thomas, Simon and Zitvogel, Laurence},
  title = {Microbiota-centered interventions to boost immune checkpoint blockade therapies},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20250378}
}
Kostenlos starten →